Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against hepatocellular carcinoma
L. Caraballo-Galva, M. Hussein, X. Jiang, H. Zhang, R. Mao, P. Brody, X. Chi, Y. Peng, A. He, M. Kehinge-Ige, R. Sadek, H. Shi, X. Qiu, Y. He
bioRxiv · Jul 9, 2021Immunology